A potential role for N-acetylcysteine in the management of methamphetamine dependence
MetadataShow full item record
Methamphetamine dependence is a growing problem in Australia and globally. Currently, there are no approved pharmacotherapy options for the management of methamphetamine dependence. N-acetylcysteine is one potential pharmacotherapy option. It has received growing attention as a therapy for managing addictions because of its capacity to restore homeostasis to brain glutamate systems disrupted in addiction and thereby reduce craving and the risk of relapse. N-acetylcysteine also has antioxidant properties that protect against methamphetamine-induced toxicity and it may therefore assist in the management of the neuropsychiatric and neurocognitive effects of methamphetamine. This commentary overviews the actions of N-acetylcysteine and evidence for its efficacy in treating addiction with a particular focus on its potential utility for methamphetamine dependence. We conclude that the preliminary evidence indicates a need for full-scale trials to definitively establish whether N-acetylcysteine has a therapeutic benefit and the nature of this benefit, for managing methamphetamine dependence. [McKetin R, Dean O, Baker A. L, Carter G, Turner A, Kelly P. J, Berk M. A potential role for N-acetylcysteine in the management of methamphetamine dependence.
Showing items related by title, author, creator and subject.
A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri LankaSenarathna, Ganga; Ranganathan, Shalini; Buckley, Nick; Fernandopulle, Rohini (2012)Background: Acute paracetamol poisoning is a rapidly increasing problem in Sri Lanka. The antidotes are expensive and yet no health economic evaluation has been done on the therapy for acute paracetamol poisoning in the ...
An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteinsSubramaniam, Aruljothi; Loo, Ser; Rajendran, P.; Manu, K.; Permul, E.; Li, F.; Shanmugam, M.; Siveen, K.; Park, J.; Ahn, K.; Hui, K.; Kumar, Alan Prem; Sethi, G. (2013)Recombinant tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is currently under clinical trials for cancer, however many tumor cells, including hepatocellular carcinoma (HCC) develop resistance to TRAIL-induced ...
Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis modelsMaeda, H.; Hirata, K.; Watanabe, H.; Ishima, Y.; Chuang, Victor; Taguchi, H.; Inatsu, A.; Kinoshita, M.; Tanaka, M.; Sasaki, Y.; Otagiri, M.; Maruyama, T. (2015)Since reactive oxygen species (ROS) derived from Kupffer cells (KC), especially CD68+ KC, play a key role in the induction of hepatic oxidative stress and injuries, we newly developed a polythiolated- and mannosylated-human ...